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Summary
Background. Women with opioid use disorders who have unintended pregnancies face unique challenges. A common 
strategy for preventing unintended pregnancies among these women is to increase their use of long acting reversible 
contraception (LARC), especially the implant and intrauterine device. This study aimed to assess the pregnancy history, 
contraceptive use and access to contraceptive services of women attending Cork-Kerry Community Healthcare (CKCH) 
for opioid replacement therapy. The need for a contraceptive service within the Addiction Services at CKCH was evalu-
ated. Methods. The study utilized a cross-sectional survey administered by healthcare providers to 39 women, ages 18-
50, attending CKCH for opioid replacement therapy. Descriptive statistics were performed using IBM SPSS Statistics 
Data Editor. Results. 79.5% of participants had unintended pregnancies, and 23% had 3 or more unintended pregnancies. 
Of the participants’ children, 35% lived with their mother, 37% lived in care, and 24% lived with another family member. 
31% of participants reported never having used LARC. 18% of participants reported never having received information 
on pregnancy prevention and 21% reported never having received information on STI prevention. 92% of participants 
reported that they would use a contraceptive service if it were provided within the addiction services at CKCH. Conclu-
sions. This study highlights the need to increase contraceptive services for women attending CKCH for opioid replace-
ment therapy. Addiction services are ideal locations to also access contraceptive services because service-users already 
attend these clinics frequently for treatment, and thus have continuity of care with healthcare providers.
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1. Introduction
In Ireland, there is an estimated 6,000 women 
with opioid use disorders [16]. These women face 
numerous difficulties. The majority have experienced 
troubled upbringings and have subsequently devel-
oped maladaptive adult relationships [6,8], Most have 
low socioeconomic status [15] and many have comor-
bid mental health disorders [6]. These factors contrib-
ute to low self-esteem, poor self-efficacy and feelings 
of shame [6], which are exacerbated by recurrent ex-
periences of social stigma [17]. Women with opioid 
use disorders often use substances for temporary re-
lief from their painful memories and current difficul-
ties [6].
In regard to reproductive health, women with 
opioid use disorders face unique challenges. Long 
term use leads to amenorrhea (absent menstruation) 
[15], which often leads women to mistakenly believe 
they are not at risk of becoming pregnant. Women 
with opioid use disorders are also more likely to en-
gage in high-risk sexual behaviors, including having 
multiple sexual partners, being involved in the sex 
trade, having sex for drugs and having sex while in-
toxicated [4]. In addition, they are at increased risk of 
being sexually abused, and studies indicate that ap-
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proximately 55% report having been raped [7]. Fur-
thermore, studies have shown that women with opioid 
use disorders have low rates of effective contraceptive 
use, with approximately 50% using no form of con-
traception [17]. 
Misperceptions about infertility, high-risk sexu-
al behaviors and low rates of effective contraceptive 
use increase the likelihood of unintended pregnan-
cies. While all women who experience unintended 
pregnancies face consequences, there are distinct 
repercussions for women with opioid use disorders. 
Compared to women without substance use disor-
ders, women with opioid use disorders are at a higher 
risk of obstetrical complications, including placental 
abruption, preeclampsia [8], ectopic pregnancy [6], 
and pregnancy loss due to miscarriage or stillbirth [4]. 
These women are also at a higher risk of death during 
pregnancy and following pregnancy termination [14]. 
Babies of women with opioid use disorders are more 
likely to be born premature and to have low birth 
weight, growth retardation, neurobehavioral deficits 
and neonatal abstinence syndrome [15]. Furthermore, 
women with opioid use disorders commonly use oth-
er substances which pose additional risks to babies, 
such as alcohol and cocaine, which can cause fetal 
alcohol syndrome and cardiovascular malformations, 
respectively [13]. Many babies who survive do not 
remain in their mothers’ care. Studies show that 64% 
of children of women with opioid use disorders do 
not live with their mother [6]. In cases where women 
maintain custody, the wellbeing of both mother and 
child are significantly diminished due to the difficul-
ties of raising a child in the socially disadvantaged 
and unstable environments typical for most women 
with opioid use disorders [8].
Increasing use of effective contraception is a 
key strategy for reducing unintended pregnancies. 
The World Health Organization categorizes implants 
(e.g.“Implanon”) and intrauterine devices (IUD, 
e.g.”Mirena Coil”) as “very effective” methods of 
contraception because they provide safe and highly 
effective contraception for 3-10 years once inserted 
[5]. Implants and IUDs are the most effective types of 
long acting reversible contraception (LARC) and are 
important for women with opioid use disorders due to 
their increased sexual risks [5]. 
Several studies have shown that women with 
opioid use disorders have higher rates of unintended 
pregnancies than women without substance use disor-
ders. An Australian study of women attending opioid 
treatment programs found that 84.2% of pregnancies 
among these women were unintended [6]. A study 
in the U.S. found that 86% of pregnancies among 
women attending eight opioid treatment programs 
were unintended, and 27% were unwanted [17]. An 
additional study in the U.S. of women with opioid use 
disorders attending two drug treatment clinics found 
that 48.1% had 1-2 unintended pregnancies, 26% had 
3-4 unintended pregnancies and 19.5% had over 5 un-
intended pregnancies [12].
The present study is the first to evaluate the preg-
nancy history and contraception use of women with 
opioid use disorders in Ireland. The study examined 
women who attend addiction services at Cork-Kerry 
Community Healthcare (CKCH) for opioid replace-
ment therapy. This study aimed to assess the preg-
nancy history, contraceptive use and access to con-
traceptive services of women attending Cork-Kerry 
Community Healthcare (CKCH) for opioid replace-
ment therapy. It aimed to determine whether there is 
a need to provide contraceptive services for women 
who attend CKCH for opioid replacement therapy 
and whether women would use these services if avail-
able.
2. Method
2.1. Design of the study
The study utilized a cross-sectional question-
naire designed to gain information on participants’ 
pregnancy history, contraceptive use, access to con-
traception, and use of healthcare services for contra-
ception and STI prevention advice. We reviewed and 
drew on the existing literature, as well as validated 
surveys of related topics when creating the question-
naire. These surveys include: The National Survey 
of Sexual Attitudes and Lifestyles (UK) [9], The 
National Campaign to Prevent Teen and Unplanned 
Pregnancy (US) [18], and The National Health Statis-
tics Report on Sexual Activity and Contraceptive Use 
Among Teenagers 2011-2015 (US) [1]. The research 
team which designed the questionnaire included doc-
tors and nurses working at CKCH, doctors and nurses 
working within the HSE Homeless Service, and a 
medical student. The questionnaire was composed of 
31 questions and took 12 minutes to complete on av-
erage.
2.2. Sample
The questionnaire was administered to women 
of childbearing age (18-50) who attend CKCH for 
opioid replacement therapy. Three centres provide 
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these services within CKCH: Arbour House and Her-
on House in Cork city, and Edward Court in Tralee, 
Kerry. Three women were excluded from the study 
because they were inebriated at the time of their ap-
pointment.
2.3. Procedure
The questionnaire was administered by a doc-
tor or nurse during service users’ scheduled appoint-
ments. We provided participants with an information 
leaflet on the study and they signed a consent form to 
participate in the study.
2.4. Data analysis
Collected data was transferred to IBM SPSS 
Statistics Data Editor for analysis. Descriptive statis-
tics were performed. Ethical approval was obtained 
from the University College Cork Clinical Research 
Ethics Committee.
3. Results
3.1. Population characteristics
Thirty-nine women attending CKCH for opioid 
replacement therapy completed the questionnaire. 
The median age of participants was 32. The partici-
pants’ age and living accommodations are summa-
rized in Table 1.
3.2. Pregnancy history
84.6% (33) of participants reported having been 
pregnant and 69.2% (27) had children. The number 
of pregnancies ranged from 0-7 (median=2); and 
the number of children born ranged from 0-6 (medi-
an=2). 56.4% (22) reported having one or more preg-
nancy loss/termination. Details of pregnancy history 
are summarized in Table 2. 
79.5% (31) reported having an unintended preg-
nancy. The reported number of unintended pregnan-
cies ranged from 0-6 (median=2). 96.3% (26/27) of 
participants with children reported having had an un-
intended pregnancy. The number of unintended preg-
nancies are depicted in Figure 1.
Of participants with children, 63% (17) reported 
having children who did not live with them (exclud-
ing children who are adults). Among all participants 
who had children, 57 children were under 18. Where 
participants’ children live are illustrated in Figure 2. 
When participants were asked how important 
it was to avoid becoming pregnant right now, 84.6% 
(33) reported it was very important, 7.7% (3) reported 
that it was somewhat important, 5.1% (2) reported it 
was not at all important and 2.6% (1) reported not 
knowing.
3.3. Contraceptive methods
97.4% (38) of participants reported having used 
contraception in the past. 51.3% (21) had used very 
effective methods of contraception (IUD, implant), 
and 10.3% (4) had used very effective methods in the 
past four weeks. 53.8% (21) reported that they were 
Table 1. Population Characteristics
Median/Number
Age Median: 32
 20-29 35.9% (14)
 30-39 53.8% (21)
 40-49 10.3% (4)
Living situation
 Stable accom-
modation 79.5% (31)
 Friend’s/Family 
member’s ac-
commodation
12.8 % (5)
 Homeless Ac-
commodation 5.1% (2)
 Rough sleeping 2.6% (1)
Table 2. Pregnancy history
Median/Number
Number of pregnancies Median=2
 0 20.5% (8)
 1-2 38.5% (15)
 3-4 30.8% (12)
 5-6 12.8% (5)
 7 2.6% (1)
Number of children Median=2
 0 15.4% (6)
 1-2 43.6% (17)
 3-4 17.9% (7)
 5-6 25.6% (3)
Number of pregnancy 
losses Median=1
 0 43.6% (17)
 1-2 53.9% (21)
 3-4 2.6% (1)
 5 2.6% (1)
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currently sexually active with a man. Of these partici-
pants, 61.9% (13) reported having used very effective 
contraception, and 9.5% (2) reported using very ef-
fective methods in the past four weeks. 79.5% (31) of 
all participants had used condoms, and 5.1% (2) re-
ported use of condoms in the past four weeks. A sum-
mary of the contraceptive methods used, examined by 
category of the WHO classification of contraception 
effectiveness, is provided in Table 3. Where partici-
pants accessed contraception is presented in Table 4. 
41% (16) of all participants reported having 
used emergency contraception in the past year. The 
number of times emergency contraception was used 
ranged from 0-10 times, with 15.4% (6) having used 
it over four times. 
3.4. Contraception and STI prevention advice
82.1% (32) of participants reported having re-
ceived information on birth control or pregnancy pre-
Figure 1. Number of unintended pregnancies    
Figure 2. Living situation of participants’ children 
20.5% (8) 20.5% (8)
36% (14)
15.4% (6)
0
2.6% (1) 5.1% (2)
0
2
4
6
8
10
12
14
16
0 1 2 3 4 5 6
N
um
be
r 
of
 P
ar
tic
ip
an
ts
Number of Unintended Pregnancies
With their mother
35% (20)
In Care
37% (21)
With another family 
member
25% (14)
With their father
2% (1)
Adopted
2% (1)
Figures 1-2. Number of unintended pregnancies and living situation of participants' children
- 31 -
J. Olioff et al.: Cross-sectional study on the need to provide contraceptive services to women attending opioid-replacement therapy
3.5. Barriers to contraceptive services
When asked what barriers prevent participants 
from accessing contraceptive services, 66.7% (26) re-
ported there were none, 5.1% (2) reported that they 
would not know where to access these services, 5.1% 
(2) reported not being registered with a regular GP, 
2.6% (1) reported not wanting to discuss contracep-
vention. 76.9% (31) reported having received infor-
mation on STI prevention. Sources where participants 
received information are documented in Table 5. 
66.7% (26) of participants reported having received 
information on drugs and alcohol during pregnancy. 
When asked whether they would use a contraceptive 
clinic if it were provided within the addiction services 
at CKCH, 92.3% (36) reported they would.
Table 3. Contraceptive methods used
Total
(Ever)
Total 
(Past 4 weeks)
Currently sexually 
active (21)
(Ever)
Currently sexually 
active (21)
(Past 4 weeks)
“Moderately effective”
 Condoms 79.5% (31) 5.1% (2) 100% (21) 9.5% (2)
“Effective”
 OCP 66.7% (26) 7.7% (3) 85.7% (18) 9.5% (2)
 Patch 12.8% (5) 0 14.3% (3) 0
 Ring 2.6% (1) 0 4.8% (1) 0
 Injectable 46.3% (18) 7.7% (3) 52.4% (11) 9.5% (2)
“Very effective”
 Implant 41% (16) 7.7% (3) 47.6% (10) 4.8% (1)
 IUD 15.4% (6) 0 14.3% (3) 0
 Tubal ligation 0 0 0 0
Table 4. Where participants accessed contraception
Source Ever Past 6 months
 Service provider at CKCH 5.1% (2) 0
 Doctor or nurse at their GP’s surgery 79.5% (31) 23.1% (9)
 Sexual health/family planning/reproductive health clinic 17.9% (7) 2.6% (1)
 Pharmacy/chemist 12.8% (5) 2.6% (1)
 Shop 5.1% (2) 0
 Online 2.6% (1) 0
Table 5. Where participants received contraceptive/STI prevention advice
Source Ever Past 6 months
Contraception/birth control advice
 Service provider at CKCH 33.3 % (13) 12.8% (5)
 Doctor or nurse at their GP’s surgery 69.2% (27) 23.1% (9)
 Sexual-health/family planning/reproductive health clinic 23% (9) 0
 Chemist 2.6% (1) 0
 Hospital 7.7% (3) 0
STI prevention advice
 Service provider at CKCH 25.6% (10) 5.1% (2)
 Doctor or nurse at their GP’s surgery 53.8% (21) 5.1% (2)
 Sexual-health/family planning/reproductive health clinic 25.6% (10) 0
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fective and barrier contraception use among partici-
pants. Notably, seven (17.9%) participants reported 
never having received information on pregnancy pre-
vention, nine (21.3%) reported never having received 
information on STI prevention, and thirteen (33.3%) 
reported never having received information on drugs 
and alcohol during pregnancy. It may be assumed that 
this advice would be provided to participants by their 
GP. However, 94.9% of participants had visited their 
GP in the past six months, and only 23.9% reported 
having received contraceptive advice from their GP 
during this time. Furthermore, 30.7% of participants 
reported having never received contraceptive advice 
from their GP. There are many possible reasons for 
why GPs do not provide contraceptive advice, such 
as needing to prioritize other health concerns and not 
having adequate time to address contraception. None-
theless, these findings suggest that women on opioid 
replacement therapy require an alternative healthcare 
source to obtain consistent advice on contraception 
and STI prevention.
Over 90% of participants reported that they 
would use a contraceptive clinic if it were provided 
within the addiction services at CKCH. The addic-
tion services at CKCH are ideally located for women 
to also access contraceptive services because service 
users already attend these clinics frequently for treat-
ment. Women attend these clinics biweekly when 
they begin opioid replacement therapy and return 
at least once a month throughout their treatment. It 
would therefore be convenient for women to have 
their contraceptive needs addressed at the addiction 
services while they are there for treatment. Previous 
studies have also suggested implementing contracep-
tive services within drug treatment centres and have 
found that women at these centres reported that they 
would use these services if provided [4, 10, 15, 17]. 
Furthermore, studies have demonstrated the efficacy 
of providing contraceptive services at drug treat-
ment centres. An American study found that intro-
ducing family planning services into drug treatment 
centres increased the reported rate of contraception 
use among service users at their follow up appoint-
ments [3]. Another study of a centre that combined 
drug treatment services with obstetric care in the U.S. 
found that providing contraceptive services to women 
with substance use disorders postpartum increased 
the use of very effective methods of contraception by 
32% [8]. 
tion with their GP, 7.7% (3) reported not having a 
medical card, 7.7% (3) reported contraception not be-
ing available enough, 2.6% (1) reported being “lazy”, 
2.6% (1) reported forgetting and 5.1% (2) reported 
that their addiction is the barrier.
4. Discussion
There was a high rate of unintended pregnancies 
among women attending CKCH for opioid replace-
ment therapy. The rate found in this study (79%) is 
similar to rates noted by other studies of women at-
tending opioid treatment programs worldwide [4, 8, 
10]. This rate is significantly higher than estimates of 
women in the general population who have had unin-
tended pregnancies, which range from 31%-47% [5]. 
Many of the participants’ pregnancies did not result 
in live births, which is consistent with other research 
indicating that women with opioid use disorders are 
at a greater risk of pregnancy loss than the general 
population [12]. Of children born to participants, 
65% did not live with their mothers. 
The low rate of very effective contraception use 
found in this study likely contributed to high rates 
of unintended pregnancies among participants. Less 
than half of participants reported ever using very ef-
fective methods of contraception, including the IUD 
and implant. This is consistent with other studies that 
indicate that women with opioid use disorders have 
low rates of effective contraceptive use [17]. Moreo-
ver, many participants are currently at risk of having 
unintended pregnancies due to low rates of very effec-
tive contraception use. Of participants who reported 
being in a current sexual relationship, less than 5% re-
ported using very effective methods of contraception 
in the past four weeks, and only 33.3% had used any 
contraceptive method over the past four weeks. Fur-
thermore, 41% of all participants had used emergency 
contraception in the past year, indicating that they had 
perceived themselves as being at risk of an unintend-
ed pregnancy. An additional concern is the low rate of 
barrier contraception use (i.e. condoms) among par-
ticipants, which is necessary for STI prevention. Of 
participants who were currently sexually active 90.5% 
(19) indicated that they had not used condoms in the 
past four weeks. We did not ask participants about 
their STI history; however similar studies of women 
attending opioid treatment programs have found high 
rates of STIs among participants [7, 8, 17].
The results of the present study suggest that gaps 
in the provision of contraception and STI prevention 
advice may be contributing to low rates of very ef-
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is thus crucial in reducing the occurrence of intergen-
erational cycles of substance use disorders. 
In a study of women with opioid used disorders 
by Heil et al., the majority of participants agreed with 
the statement “In life, things just seem to happen to 
me”, indicating their perceived lack of control over 
their lives [10]. Having a contraceptive service that is 
easily accessible is especially important for women 
on opioid replacement therapy due to the unstable and 
often impoverished nature of their lives. The addic-
tion services at CKCH are ideally located for women 
to access contraceptive services because service us-
ers already attend these clinics frequently for treat-
ment. The provision of an accessible contraceptive 
service would allow these women to focus on their 
well-being and recovery, as well as empower them to 
take control of a crucial aspect of their reproductive 
health. It would allow them to make a conscious and 
autonomous choice to become pregnant when they 
wish to do so.
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